Publications by authors named "Lalchhandama Chhakchhuak"

Article Synopsis
  • The study focuses on the higher incidence of triple-negative breast cancer (TNBC) in India, specifically in Mizoram, and aims to identify novel genetic variants associated with the disease.
  • Researchers analyzed whole exome sequencing data from TNBC patients to uncover significant mutations, finding that TP53 and several other genes were frequently mutated in patients.
  • The research highlighted the presence of novel variants and potential therapeutic targets, suggesting that further exploration of specific genes could lead to advancements in TNBC treatment.
View Article and Find Full Text PDF

Background: Despite being the second least populated state, Mizoram exhibits the highest incidence rate of cancer in India. Its inhabitants, constituting an endogamous and isolated population, have embraced their own distinct culture, way of life and dietary preferences, setting them apart from the rest of mainland India. In 2003, the Mizoram Population Based Cancer Registry (PBCR) was established under the auspices of the National Centre for Disease Informatics and Research (NCDIR), a division of the Indian Council of Medical Research (ICMR), in collaboration with the Department of Health & Family Welfare of the Government of Mizoram, India.

View Article and Find Full Text PDF

Background: Autoinflammatory disorders are the group of inherited inflammatory disorders caused due to the genetic defect in the genes that regulates innate immune systems. These have been clinically characterized based on the duration and occurrence of unprovoked fever, skin rash, and patient's ancestry. There are several autoinflammatory disorders that are found to be prevalent in a specific population and whose disease genetic epidemiology within the population has been well understood.

View Article and Find Full Text PDF

Numerous drugs are being widely prescribed for COVID-19 treatment without any direct evidence for the drug safety/efficacy in patients across diverse ethnic populations. We analyzed whole genomes of 1029 Indian individuals (IndiGen) to understand the extent of drug-gene (pharmacogenetic), drug-drug and drug-drug-gene interactions associated with COVID-19 therapy in the Indian population. We identified 30 clinically significant pharmacogenetic variants and 73 predicted deleterious pharmacogenetic variants.

View Article and Find Full Text PDF

Background: There are very few studies covering the epidemiological risk factors associated with Epstein Barr Virus (EBV) and Microsatellite stability for Gastric Cancer (GC) cases. Early diagnosis of GC through epidemiological risk factors is very necessary for the clinical assessment of GC. The aim of this study was to find out the major risk factors to predict GC in early stage and the impact of pathogen infection and MSI on survival rate of patients.

View Article and Find Full Text PDF

With the advent of next-generation sequencing, large-scale initiatives for mining whole genomes and exomes have been employed to better understand global or population-level genetic architecture. India encompasses more than 17% of the world population with extensive genetic diversity, but is under-represented in the global sequencing datasets. This gave us the impetus to perform and analyze the whole genome sequencing of 1029 healthy Indian individuals under the pilot phase of the 'IndiGen' program.

View Article and Find Full Text PDF

Leukemia is the most common childhood malignancy and studies had been carried out with promising revelations in its diagnosis and prognosis. However, majority of the studies are focused on nuclear alterations, while mitochondrial mutations are not well studied. Although there are studies of mitochondrial mutations in the adult leukemias, it does not represent the same for childhood malignancy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to detect and characterize Babesia microti in laboratory mice in India, utilizing blood smear examination and PCR techniques.
  • A total of 625 mice were tested, revealing an overall infection rate of 8.80% for B. microti, with species-specific PCR yielding higher detection rates compared to blood smears.
  • Findings suggest that laboratory mice might act as a reservoir for human infection, emphasizing the need for improved diagnosis and control of human babesiosis.
View Article and Find Full Text PDF